| pubmed-article:12686658 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0024141 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0025926 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C1513867 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0004358 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0209368 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C1527148 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C1709059 | lld:lifeskim |
| pubmed-article:12686658 | lifeskim:mentions | umls-concept:C0033268 | lld:lifeskim |
| pubmed-article:12686658 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:12686658 | pubmed:dateCreated | 2003-4-10 | lld:pubmed |
| pubmed-article:12686658 | pubmed:abstractText | Mycophenolate mofetil (MMF) has been successfully used to improve or prevent the development of systemic lupus erythematosus (SLE) in both humans and in several lupus-prone mice. In the present study, we evaluated mechanisms through which MMF may exert its therapeutic effect on the development of systemic autoimmunity. | lld:pubmed |
| pubmed-article:12686658 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12686658 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686658 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12686658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686658 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12686658 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12686658 | pubmed:month | May | lld:pubmed |
| pubmed-article:12686658 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:AriasManuelM | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:PiñeraCelesti... | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:RamosMaria... | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:SetiénMaria... | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:BueltaLuisL | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:de CosMaria... | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:de... | lld:pubmed |
| pubmed-article:12686658 | pubmed:author | pubmed-author:MerinoRamónR | lld:pubmed |
| pubmed-article:12686658 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12686658 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:12686658 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12686658 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12686658 | pubmed:pagination | 878-83 | lld:pubmed |
| pubmed-article:12686658 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:meshHeading | pubmed-meshheading:12686658... | lld:pubmed |
| pubmed-article:12686658 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12686658 | pubmed:articleTitle | Modulation of autoantibody production by mycophenolate mofetil: effects on the development of SLE in (NZB x NZW)F1 mice. | lld:pubmed |
| pubmed-article:12686658 | pubmed:affiliation | Servicio de Nefrología, Unidad de Investigación, Hospital Universitario Marqués de Valdecilla, Av. Valdecilla s/n, E-39008 Santander, Spain. | lld:pubmed |
| pubmed-article:12686658 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12686658 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12686658 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12686658 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12686658 | lld:pubmed |
